Biotech Alumna to Give Commencement Address

Alumna Eneda Hoxha (’08) will give the commencement address during graduation, Dec. 13

Hoxha is a biotech executive focused on building companies that turn rigorous science into real therapies. She serves as vice president at Nurix Therapeutics, working at the intersection of science, strategy and law to help shape how breakthrough medicines are discovered, protected and scaled. A molecular biologist turned company builder, she began her career as a scientist at the bench, then litigated intellectual property on some of the world’s best-selling drugs before deciding she’d rather help build the next generation of them instead. Since then, she has helped advance first-in-class degraders, RNA medicines and gene-editing therapies through intellectual property, legal and business development strategy. 

In addition to a bachelor’s degree from Truman, Hoxha has a Ph.D. from Northwestern University and a J.D. from the University of California, Berkeley School of Law. 

Truman will conduct fall commencement at 11 a.m. Dec. 13 in Pershing Arena. For more information, click here.